| Kürzel | Analyse | Material | |
|---|---|---|---|
| INFLIXI | Infliximab | MATERIAL: Serum gefroren, METHODE: EIA | |
| INFLIXIAK | Infliximab Antikörper | MATERIAL: Serum gefroren, METHODE: EIA | |
| INFLPCR | Influenza A-/B PCR | MATERIAL: Nasensekret, METHODE: PCR | |
| INHIBINA | Inhibin A (Dimer) | MATERIAL: Serum, METHODE: | |
| INHIBINB | Inhibin B | MATERIAL: Serum/Vollblut, METHODE: | |
| INR | PT/INR (int.normalized ratio) | MATERIAL: Citrat, METHODE: kalkulatorisch | |
| INSUL | Insulin | MATERIAL: Serum/Vollblut, METHODE: MEIA | |
| INSULG | Insulin-AK IgG | MATERIAL: Serum/Vollblut, METHODE: ELISA | |
| INTRFAKA | Intrinsic Faktor AK | MATERIAL: Serum, METHODE: ELISA | |
| INTRFAKAW | Intrinsic Faktor AK | MATERIAL: Serum/Vollblut, METHODE: Immunfluoreszenz | |
| ITRACO_GES | Itraconazol+Hydroxyitraconazol | MATERIAL: Serum, METHODE: Berechnet | |
| JAK2_EXON | JAK2 Exon12 Mutationsnachweis | MATERIAL: EDTA 5ml; Methode: PCR | |
| JAK2_V617F | JAK2 V617F Mutationsnachweis | MATERIAL: EDTA 5ml; Methode: PCR | |
| JAPENZEPHG | Japan.-Enz.-Virus IgG | MATERIAL: Serum, METHODE: IFT | |
| JAPENZEPHM | Japan.-Enz.-Virus IgM | MATERIAL: Serum, METHODE: IFT | |
| JCVPCR | JC-Polyomavirus DNA (PCR) | MATERIAL: EDTA-Blut; METHODE: PCR | |
| JO1 | Jo-1 | MATERIAL: Serum/Vollblut, METHODE: Immunoblot | |
| JODS | Jod im Serum | MATERIAL: Serum; Methode: ICP-MS | |
| JODU | Jod i.H. | MATERIAL: Spontanharn; Methode: ICP-MS | |
| JODUKR | Jod /g Krea i.H. | Material: Spontanharn; Methode: ICP-MS |